Authors/Disclosures
|
Michael D. Hill, MD
(University of Calgary)
|
Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular. |
|
Caitlin Wright
(University of Calgary)
|
No disclosure on file |
|
|
No disclosure on file |
|
Renee Martin
|
No disclosure on file |
|
|
No disclosure on file |
|
Ross Mitchell
|
No disclosure on file |
|
|
No disclosure on file |
|
Andrew M. Demchuk, MD
(Foothills Hospital/Calgary Stroke Program)
|
Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lumosa. Dr. Demchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer/BMS. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Demchuk has received stock or an ownership interest from Circle NVI. Dr. Demchuk has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Myron D. Ginsberg, MD, FAAN
(University of Miami Miller School of Medicine)
|
No disclosure on file |
|
Yuko Palesch
|
No disclosure on file |